Samuel M.cohenProfessor | Omaha, Nebraska
Samuel M. Cohen (MD, PhD, University of Wisconsin, 1972) completed an anatomic and clinical pathology residency (St. Vincent Hospital, Worcester, Massachusetts, 1975), and was board certified (1976). He was visiting professor, Nagoya City University Medical School (1976–1977), staff pathologist at St. Vincent Hospital (1975–1981), and associate professor, pathology, University of Massachusetts Medical School (1977–1981). In 1981 he became Professor and Vice Chairman of Pathology and Microbiology, University of Nebraska Medical Center, and Chairman 1992–2007.
Dr. Cohen’s research has focused on carcinogenesis mechanisms, especially the role of cell proliferation. In addition, his research has involved clinical investigations, extrapolation between animals and humans, and risk assessment. This research has resulted in more than 400 publications. He has been a member of numerous NIH, US EPA, US FDA, WHO, IARC, and NAS scientific panels, was a member of the NTP Board of Scientific Counselors (BSC) and the NIEHS BSC. He was recipient of the SOT’s Lehman Award (2001), Distinguished Scientist in Cancer Research by the Japanese Foundation for Cancer Research (2004), and the George H. Scott Award from Toxicology Forum and Lifetime Achievement Award from the Association for Environmental Health and Science (2012).
He continues to be active in human surgical pathology and is listed as one of the “Best Doctors in America.” He has been actively involved with ILSI, RSI, and HESI since 1985, member of the HESI Board of Trustees since 2001 (Chairman, 2006–2008) and the ILSI Board since 2007 (Chairman, 2012–2014). He has been active in the Carcinogenesis Specialty Section of SOT (President, 2002), the Central States Chapter (President, 2004–2005), and several SOT committees. He is a fellow of the Academy of Toxicological Sciences (1995) and International Academy of Toxicologic Pathology (2003).